Phenotypic characterization of osteoblasts from the sclerotic zones of osteoarthritic subchondral bone
Open Access
- 31 January 2008
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 58 (2) , 442-455
Abstract
Objective: To determine the phenotype of osteoblasts from the sclerotic zones of human osteoarthritic (OA) subchondral bone.Methods: Human osteoblasts were isolated from sclerotic or nonsclerotic areas of subchondral bone and cultured for 14 days in monolayer. The expression of 14 genes was investigated by real‐time reverse transcription–polymerase chain reaction. The activities of alkaline phosphatase (AP) and transglutaminases (TGases) were quantified by enzymatic assays. C‐terminal type I procollagen propeptide (CPI), interleukin‐1β (IL‐1β), IL‐6, IL‐8, transforming growth factor β1 (TGFβ1), osteocalcin (OC), and osteopontin (OPN) were assayed in the culture medium by immunoassay.Results: Gene expression levels of matrix metalloproteinase 13, COL1A1 and COL1A2, OPN, tissue‐nonspecific AP, OC, vascular endothelial growth factor, ANKH, TGase 2, factor XIIIA, and dentin matrix protein 1 were significantly up‐regulated in sclerotic osteoblasts compared with nonsclerotic osteoblasts. In contrast, parathyroid hormone receptor gene expression was depressed in sclerotic osteoblasts, but bone sialoprotein levels were unchanged. The activities of AP and TGases were increased in sclerotic osteoblasts, while matrix mineralization, revealed by alizarin red staining, was decreased. In parallel, protein synthesis of CPI, OC, OPN, IL‐6, IL‐8, and TGFβ1 was significantly higher in sclerotic osteoblasts than in nonsclerotic osteoblasts, while IL‐1β production was similar in both groups.Conclusion: These findings contribute to a better understanding of the mechanisms involved in subchondral bone sclerosis and identify osteoblasts with an altered phenotype as a potential target for future OA therapies.Keywords
This publication has 46 references indexed in Scilit:
- Osteopontin promotes pathologic mineralization in articular cartilageMatrix Biology, 2007
- Transforming Growth Factor-β1 Regulation of Collagenase-3 Expression in Osteoblastic Cells by Cross-talk between the Smad and MAPK Signaling Pathways and Their Components, Smad2 and Runx2Journal of Biological Chemistry, 2004
- Can altered production of interleukin-1β, interleukin-6, transforming growth factor-β and prostaglandin E2 by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patientsOsteoarthritis and Cartilage, 2002
- Mechanical and Architectural Bone Adaptation in Early Stage Experimental OsteoarthritisJournal of Bone and Mineral Research, 2002
- Endogenous Prostaglandin E2 and Insulin-like Growth Factor 1 Can Modulate the Levels of Parathyroid Hormone Receptor in Human Osteoarthritic OsteoblastsJournal of Bone and Mineral Research, 2001
- Abnormal regulation of urokinase plasminogen activator by insulin-like growth factor 1 in human osteoarthritic subchondral osteoblastsArthritis & Rheumatism, 1999
- Degenerative joint disease in the guinea pig. Use of magnetic resonance imaging to monitor progression of bone pathologyArthritis & Rheumatism, 1996
- Human osteoclasts, not osteoblasts, deposit osteopontin onto resorption surfaces: An in vitro and ex vivo study of remodeling boneJournal of Bone and Mineral Research, 1995
- Regulation of insulin-like growth factor I transcription by prostaglandin E2 in osteoblast cellsEndocrinology, 1995
- Subchondral bone in osteoarthritisCalcified Tissue International, 1991